NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

The so called “4 day rule” is not an FDA or SEC rule, or regulation. It’s merely a best practice in flatly unambiguous circumstances, and only to avoid possible litigation, so it’s not really a legal rule of any agency, it is a way that one might best avoid possible trouble, in very specific circumstances. It’s not what people think it is. It makes sense in simple trials where you’d have a situation that is unambiguous. It is deeply problematic where, and this is common in clinical trials, circumstances might look or be perceived one way and then the regulatory circumstance goes the other way, in either direction.

But the more absurd circumstance is the bulletin board and Twitter promoted notion that has been turned into a fake axiom for when you know a trial has succeeded, which logically, is ridiculous. The false notion that lack of disclosure means they have succeeded because “the 4 day rule”... which does not even make sense.